GRM2 and schizophrenia: Indeed, presynaptic/glial mGluR2/3 is a prime target to counter dysregulated PFC glutamate signaling observed in schizophrenia (Patil et al., 2007; Moghaddam and Javitt, 2012; Vinson and Conn, 2012).